The diagnostic value of fecal calprotectin and lactoferrin is still under debate [133]; however, only the American Gastroenterological Association (AGA) guidelines suggest the early use of fecal markers in patients with ≥grade 2 diarrhea/colitis in order to identify who need endoscopic assessment [112]. This evidence concerns the gene LTF and colitis.